AveXis - Articles and news items

AveXis gains EU Orphan Drug designation for gene therapy treatment in spinal muscular atrophy

Industry news / 24 June 2015 / Victoria White

EMA grants Orphan Drug designation to AveXis’ gene transfer therapeutic currently in clinical development for the treatment of spinal muscular atrophy…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+